Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
2016 ◽
Vol 56
(6)
◽
pp. 649-660
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 58
(5)
◽
pp. 639-649
◽
Keyword(s):
Keyword(s):